Dentsply Sirona director granted 22,822 RSUs

HOLDEN BETSY D reported acquisition or exercise transactions in this Form 4 filing.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

HOLDEN BETSY D reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. director Betsy D. Holden received an equity grant of 22,822 shares of Common Stock in the form of Restricted Stock Units. The RSUs vest in full one year from the grant date, meaning restrictions lapse at that time. Following this award, she holds a total of 77,441.799 shares directly.

Insider Trade Summary

Grant/Award: 22,822 shares

Grant/Award 1 txn

Insider HOLDEN BETSY D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	22,822	$0.00	$0.00

Holdings After Transaction: Common Stock — 77,441.799 shares (Direct)

Footnotes (1)

F1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Key Figures

RSU grant size: 22,822 shares Grant price: $0.0000 per share Post-grant holdings: 77,441.799 shares +2 more

5 metrics

RSU grant size 22,822 shares Restricted Stock Units awarded to director on 2026-06-03

Grant price $0.0000 per share Compensation grant, not an open-market purchase

Post-grant holdings 77,441.799 shares Common Stock held directly after the transaction

Vesting schedule 1 year from grant RSUs vest in full one year from grant date

Transaction code A Grant, award, or other acquisition of Common Stock

Key Terms

Restricted Stock Units (RSUs), vest in full, Common Stock, Grant, award, or other acquisition

4 terms

Restricted Stock Units (RSUs) financial

"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

vest in full financial

"Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year"

Common Stock financial

"security_title: Common Stock; total_shares_following_transaction: 77441.7990"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DENTSPLY SIRONA (XRAY) director Betsy Holden report?

Betsy D. Holden reported receiving a grant of 22,822 shares of DENTSPLY SIRONA Common Stock as Restricted Stock Units. This was a compensation-related award at no purchase price, recorded as an acquisition rather than an open-market share purchase.

How do Betsy Holden’s new RSUs at DENTSPLY SIRONA (XRAY) vest?

The grant consists entirely of Restricted Stock Units that vest in full one year from the grant date. When vesting occurs, the restrictions lapse, and the units are expected to convert into common shares subject to applicable tax and company policies.

How many DENTSPLY SIRONA (XRAY) shares does Betsy Holden own after this Form 4?

After the reported grant, Betsy D. Holden holds 77,441.799 shares of DENTSPLY SIRONA Common Stock directly. This figure reflects her position following the 22,822-share RSU award disclosed in the Form 4 insider filing.

Was Betsy Holden’s DENTSPLY SIRONA (XRAY) transaction an open-market buy or a grant?

The transaction was a grant or award acquisition, not an open-market purchase. She received 22,822 Restricted Stock Units at a price of $0.0000 per share as part of compensation, classified under transaction code “A” for grants or awards.

What does Betsy Holden’s RSU grant mean for DENTSPLY SIRONA (XRAY) shareholders?

The RSU grant represents routine director equity compensation rather than a market trade. It modestly increases potential future share count when the units vest in one year but primarily aligns the director’s interests with shareholders through stock-based incentives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/05/2026 - 05:31 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOLDEN BETSY D

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

NORTH CAROLINA

28277

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/03/2026		A		22,822⁽¹⁾	A	$0	77,441.799	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Betsy D. Holden	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR